Pharmacogenetics of ugt genes in North African populations

M Gaibar¹, A Novillo¹, A Romero-Lorca¹, M E Esteban^{2

3}, A Fernández-Santander⁴

Affiliations

¹ Biomedical and Health Sciences Faculty, Universidad Europea de Madrid, Tajo s/n, 28670, Villaviciosa de Odón, Madrid, Spain.
² Faculty of Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain.
³ Institut de Reçerca de la Biodiversitat (IRBio), University of Barcelona, Barcelona, Spain.
⁴ Biomedical and Health Sciences Faculty, Universidad Europea de Madrid, Tajo s/n, 28670, Villaviciosa de Odón, Madrid, Spain. ana.fernandez@universidadeuropea.es.

M Gaibar et al. Pharmacogenomics J. 2018 Sep.

. 2018 Sep;18(5):609-612.

doi: 10.1038/s41397-018-0034-4. Epub 2018 Jul 31.

M Gaibar¹, A Novillo¹, A Romero-Lorca¹, M E Esteban^{2

3}, A Fernández-Santander⁴

¹ Biomedical and Health Sciences Faculty, Universidad Europea de Madrid, Tajo s/n, 28670, Villaviciosa de Odón, Madrid, Spain.
² Faculty of Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain.
³ Institut de Reçerca de la Biodiversitat (IRBio), University of Barcelona, Barcelona, Spain.
⁴ Biomedical and Health Sciences Faculty, Universidad Europea de Madrid, Tajo s/n, 28670, Villaviciosa de Odón, Madrid, Spain. ana.fernandez@universidadeuropea.es.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

1. Novillo A, Romero-Lorca A, Gaibar M, Rubio M, Fernández-Santander A. Tamoxifen metabolism in breast cancer treatment: taking the focus off the CYP2D6 gene. Pharm J. 2017;17:109–11. - PubMed
1. Masimirembwa C, Dandara C, Leutscher PD. Rolling out efavirenz for HIV precision medicine in Africa: are we ready for pharmacovigilance and tackling neuropsychiatric adverse effects? OMICS. 2016;20:575–580. doi: 10.1089/omi.2016.0120. - DOI - PubMed
1. Matimba A, Del‐Favero J, Van Broeckhoven C, Masimirembwa C. Novel variants of major drug‐metabolising enzyme genes in diverse African populations and their predicted functional effects. Hum Genom. 2009;3:169–90. doi: 10.1186/1479-7364-3-2-169. - DOI - PMC - PubMed
1. Dandara C, Swart M, Mpeta B, Wonkam A, Masimirembwa C. Cytochrome P450 pharmacogenetics in African populations: implications for public health. Expert Opin Drug Metab Toxicol. 2014;10:769–85. doi: 10.1517/17425255.2014.894020. - DOI - PubMed
1. Alessandrini M, Asfaha S, Dodgen TM, Warnich L, Pepper MS. Cytochrome P450 pharmacogenetics in African populations. Drug Metab Rev. 2013;45:253–75. doi: 10.3109/03602532.2013.783062. - DOI - PubMed